Combination treatment in autoimmune diseases — Introduction W. B. HarrisonB. A. C. Dijkmans General Section Pages: 3 - 4
Combination therapy for autoimmune diseases: the rheumatoid arthritis model N. FathyDaniel E. Furst General Section Pages: 5 - 26
Regulatory aspects of evaluating combination treatments in autoimmune diseases Pekka Kurki General Section Pages: 35 - 41
New therapies in development for autoimmune diseases: their rationale for combination treatment Vibeke Strand General Section Pages: 43 - 61
Combination therapy: the risks of infection and tumor induction David E. Yocum General Section Pages: 63 - 72
Combination treatment in autoimmune diseases: systemic lupus erythematosus G. MoroniO. Delia Casa AlberighiClaudio Ponticelli Disease Specific Section Pages: 75 - 89
Combination therapy in autoimmune disease: vasculitis David M. CarruthersP. Bacon Disease Specific Section Pages: 91 - 108
Combination therapies for systemic sclerosis C. P. DentonCarol M. Black Disease Specific Section Pages: 109 - 129
Therapy of Sjögren’s syndrome Niki M. MoutsopoulosH. M. Moutsopoulos Disease Specific Section Pages: 131 - 145
Spondylarthropathies: options for combination therapy A. M. van TubergenRobert B. M. LandewéSjef van der Linden Disease Specific Section Pages: 147 - 163
Combination therapy in rheumatoid arthritis S. BinghamPaul Emery Disease Specific Section Pages: 165 - 183
What will treatment of autoimmune diseases entail in 2010? Tom W. J. HuizingaF. C. Breedveld Futurology Pages: 187 - 192